For mRNA Vaccines, COVID-19 Is Just the Beginning
For mRNA Vaccines, COVID-19 Is Just the Beginning Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases. By Michael Eisenstein | January 29, 2021 Even the experts were startled by the remarkable success of the two first-of-their-kind messenger RNA (mRNA) vaccines developed by Moderna and Pfizer/BioNTech against COVID-19. “If you had told me before that there would be 95% effectiveness for these vaccines, I’d have said you were dreaming,” says Andrew Pekosz, PhD, a professor in Molecular Microbiology and Immun...
Source: jhsph.edu